Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$7.24 -0.59 (-7.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Other Accumulated Expenses (2024)

Updated

Eupraxia Pharmaceuticals' Other Accumulated Expenses was $158,944 in the quarter ended Mar 31, 2024.

Analysis

Eupraxia Pharmaceuticals (EPRX) Other Accumulated Expenses (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Eupraxia Pharmaceuticals 289.28 Mn 287.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 158,944.00
API Access

Eupraxia Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=EPRX&period=max&api_key=YOUR_API_KEY